Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-02-27
2007-02-27
Siew, Jeffrey (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S328000, C530S330000
Reexamination Certificate
active
10174692
ABSTRACT:
Two synthetic peptides, Atroporin (AT) and Kaotree (KT), each consisting of ten amino acids and their use for the treatment and/or prevention of various types of cancers is disclosed. The amino acid sequence from the N-terminal for AT is Phe-Cys-Arg-Phe-Leu-Leu-Cys-Pro-Ser-Arg, and for KT is Pro-Pro-Gly-Asn-Gln-Pro-Asp-Ala-Asp-Ser.
REFERENCES:
patent: 4672107 (1987-06-01), Kilmon
patent: 5565431 (1996-10-01), Lipps et al.
patent: 6551795 (2003-04-01), Rubenfield et al.
Lipps Binie V.
Lipps Frederick W.
Casperson John R
Fetterolf Brandon
Siew Jeffrey
LandOfFree
Two synthetic peptides for treatment and prevention of cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Two synthetic peptides for treatment and prevention of cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Two synthetic peptides for treatment and prevention of cancers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3808811